Catalyst Wire Dossier Catalyst Wire Dossier

Lorundrostat

lorundrostat · Mineralys Therapeutics Inc.
Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for Lorundrostat, covering 2025-07-08 to 2026-06-03. Get the full timeline:

Most recent: Clinical Trial Results: Efficacy and Safety of Lorundrostat in Addition to Sodium-Glucose Cotransporter-2 Inhibitors (SGLT2i) in Subjects With Hypertension and Chronic Kidney Disease (CKD) With Albuminuria [Phase 2]

See pricing